Intraoperatory Radiolocalization (RLI) and Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS): our experience
β Scribed by A.V Granai; O Buonomo; C.A Pistolese; E Cossu; G Palmieri; A Felici; D Forcella; D Mineo; O Schillaci; T.C Mineo
- Book ID
- 118622057
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 165 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with oc
Sentinel lymph node biopsy is frequently associated with identification of micrometastatic tumor deposits. The clinical relevance of identifying micrometastases in breast cancer must be evaluated in the statistical context of the lymph node evaluation strategy and the likelihood of missing a metasta